Clinical trial

Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and…

NCT00004547 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00004547
Title Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
Official title Phase II Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-Fluorouracil for Peritoneal Carcinomatosis
Lead sponsor National Cancer Institute (NCI), NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Abdominal Neoplasm, Colonic Neoplasm, Mesothelioma, Peritoneal Neoplasm
Intervention type Drug, Procedure
Interventions Surgery, Continuous hyperthermic peritoneal perfusion (CHPP) with Cisplatin, Postoperative dwell with paclitaxel and 5-FU
Enrollment 188
Start date Jan 1, 2000
Primary completion Aug 1, 2009
Completion Aug 1, 2009
First posted Feb 4, 2000
Last update posted Nov 18, 2015
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies